Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Fusafungine
Introduction
Overview
Overview
Fusafungine (INN), also known as fusafungin, is an active agent used in antibiotics for treatment of nasal and throat infection. It also possesses anti-inflammatory properties. Fusafungine is a mixture of enniatin cyclohexadepsipeptides made up of alternating D-α-hydroxyvaleric acid and L–N-methylamino acid residues,[2] produced by the ascomycete Fusarium lateritium, and marketed by Servier under the trade names Locabiotal, Bioparox, and Locabiosol.
According to a pooled analysis study done in the UK for the efficacy of fusafungine in rhinopharingitis, it was found that the proportion of patients who showed an improvement in symptoms from Day 0 to Day 4 of infection was 61.5% with fusafungine vs. 46.8% when compared to a placebo.[3]
References
References
- ↑ Fusafungine at MeSH
- ↑ Daniel Levy, Aline Bluzat, Michel Seigneuret and Jean-Louis Rigaud (1995). “Alkali cation transport through liposomes by the antimicrobial fusafungine and its constitutive enniatins”. Biochemical Pharmacology. 50 (12 22): 2105–2107. doi:10.1016/0006-2952(95)02045-4. PMID 8849339.
- ↑ PMID 15626253 (PMID 15626253)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]